Marshall Kadin, MD
Professor
Boston University School of Medicine
Dept of Dermatology

MD, Northwestern University




Dr. Marshall Kadin is a current Professor of Dermatology at the Boston University School of Medicine. His current research involves investigating the role of cytokines in the pathogenesis of cutaneous T cell lymphomas.

Roger Williams Medical Center


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kadin ME. Commentary on: A Case Report of a Breast Implant-Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant-Associated Neoplasms. Aesthet Surg J. 2019 Jun 21; 39(7):NP240-NP242. PMID: 31220209.
     
  2. Zhang JP, Song Z, Wang HB, Lang L, Yang YZ, Xiao W, Webster DE, Wei W, Barta SK, Kadin ME, Staudt LM, Nakagawa M, Yang Y. A novel model of controlling PD-L1 expression in ALK+ Anaplastic Large Cell Lymphoma revealed by CRISPR screening. Blood. 2019 May 31. PMID: 31151983.
     
  3. Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, Jacobs HK, Zeng Y, Hundal T, Rech KL, Ketterling RP, Lee JH, Eckloff BW, Yan H, Gaonkar KS, Tian S, Ye Z, Kadin ME, Sidhu J, Jiang L, Voss J, Link BK, Syrbu SI, Facchetti F, Bennani NN, Slager SL, Ordog T, Kocher JP, Cerhan JR, Ansell S, Feldman AL. Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma. Blood. 2019 May 17. PMID: 31101622.
     
  4. Hanson SE, Hassid VJ, Branch-Brooks C, Liu J, Kadin ME, Miranda R, Butler CE, Clemens MW. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2019 Feb 21. PMID: 30789639.
     
  5. Kadin ME. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019 Jan 31; 39(Supplement_1):S28-S35. PMID: 30715174.
     
  6. Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, Adams WP, Bacchi CE, Goes JCS, Clemens MW, Medeiros LJ, Miranda RN. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis. Hum Pathol. 2018 08; 78:54-62. PMID: 29689246.
     
  7. Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y. SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile. J Invest Dermatol. 2018 08; 138(8):1795-1804. PMID: 29510190.
     
  8. Yi S, Sun J, Qiu L, Fu W, Wang A, Liu X, Yang Y, Kadin ME, Tu P, Wang Y. Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment. J Invest Dermatol. 2018 05; 138(5):1126-1136. PMID: 29248547.
     
  9. Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 09 01; 37(8):NP88-NP89. PMID: 29036946.
     
  10. Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493; DOI: 10.1093/asj/sjw286;.
     
Showing 10 of 275 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 263 publications over 40 distinct years, with a maximum of 15 publications in 1996

YearPublications
19802
19813
19823
19833
19843
19858
19865
19879
19888
19896
19908
19917
19926
19937
19949
19959
199615
199710
199814
19999
200012
20019
200210
200312
20046
20054
20063
20075
20084
20093
20106
20114
20122
20134
20149
20154
20166
20179
20182
20195
Contact for Mentoring:


25 Buick St
Boston MA 02215
Google Map


Kadin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department